Literature DB >> 27012547

Anticonvulsant drug-induced cell death in the developing white matter of the rodent brain.

Suhasini Kaushal1, Zenab Tamer1, Freda Opoku1, Patrick A Forcelli1.   

Abstract

OBJECTIVE: During critical periods of brain development, both seizures and anticonvulsant medications can affect neurodevelopmental outcomes. In rodent models, many anticonvulsants trigger neuronal apoptosis. However, white matter apoptosis (WMA) has not been examined after anticonvulsant drug treatment. Herein, we sought to determine if anticonvulsant drugs induced apoptosis in the developing white matter (WM) in a rodent model.
METHODS: Postnatal day (P)7 rats were treated with phenobarbital (PB-75), MK-801 (dizocilpine, 0.5), lamotrigine (LTG-20), carbamazepine (CBZ-100), phenytoin (PHT-50), levetiracetam (LEV-250), or saline; all doses are mg/kg. Brain tissue collected 24 h after treatment was stained using the terminal deoxynucleotidyl transferase dUTP nick end labeling method. The number of degenerating cells within WM, that is, anterior commissure (AC), corpus callosum, cingulum, and hippocampus-associated WM tracts, was quantified.
RESULTS: Saline-treated rats showed low baseline level of apoptosis in developing WM on P8 in all the areas examined. PB, PHT, and MK-801 significantly increased apoptosis in all four brain areas examined. Exposure to CBZ, LTG, or LEV failed to increase apoptosis in all regions. SIGNIFICANCE: Commonly used anticonvulsants (PB, PHT) cause apoptosis in the developing WM in a rat model; the N-methyl-d-aspartate (NMDA) receptor antagonist MK-801 has a similar effect. These results are consistent with reports of anesthesia-induced WMA during brain development. Consistent with the lack of neuronal apoptosis caused by LTG, LEV, and CBZ, these drugs did not cause WMA. Many infants treated with anticonvulsant drugs have underlying neurologic injury, including WM damage (e.g., following intraventricular hemorrhage [IVH] or hypoxic-ischemic encephalopathy [HIE]). The degree to which anticonvulsant drug treatment will alter outcomes in the presence of underlying injury remains to be examined, but avoiding drugs (when possible) that induce WMA may be beneficial. Wiley Periodicals, Inc.
© 2016 International League Against Epilepsy.

Entities:  

Keywords:  Anticonvulsant; Antiepileptic drug; Apoptosis; Cell death; Neonatal

Mesh:

Substances:

Year:  2016        PMID: 27012547      PMCID: PMC5214662          DOI: 10.1111/epi.13365

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  44 in total

1.  Melatonin potentiates the anticonvulsant action of phenobarbital in neonatal rats.

Authors:  Patrick A Forcelli; Colin Soper; Anne Duckles; Karen Gale; Alexei Kondratyev
Journal:  Epilepsy Res       Date:  2013-10-05       Impact factor: 3.045

2.  Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

Authors:  C Ikonomidou; F Bosch; M Miksa; P Bittigau; J Vöckler; K Dikranian; T I Tenkova; V Stefovska; L Turski; J W Olney
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

3.  Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain.

Authors:  Chainllie Young; Vesna Jevtovic-Todorovic; Yue-Qin Qin; Tatyana Tenkova; Haihui Wang; Joann Labruyere; John W Olney
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

4.  Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain.

Authors:  Jun-Heum Yon; Lisa B Carter; Russel J Reiter; Vesna Jevtovic-Todorovic
Journal:  Neurobiol Dis       Date:  2005-11-10       Impact factor: 5.996

5.  Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain.

Authors:  Ansgar M Brambrink; Alex S Evers; Michael S Avidan; Nuri B Farber; Derek J Smith; Xuezhao Zhang; Gregory A Dissen; Catherine E Creeley; John W Olney
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

6.  Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome.

Authors:  C Ikonomidou; P Bittigau; M J Ishimaru; D F Wozniak; C Koch; K Genz; M T Price; V Stefovska; F Hörster; T Tenkova; K Dikranian; J W Olney
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

7.  Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain.

Authors:  Ansgar M Brambrink; Alex S Evers; Michael S Avidan; Nuri B Farber; Derek J Smith; Lauren D Martin; Gregory A Dissen; Catherine E Creeley; John W Olney
Journal:  Anesthesiology       Date:  2012-02       Impact factor: 7.892

8.  Phenobarbital modifies seizure-related brain injury in the developing brain.

Authors:  M A Mikati; G L Holmes; A Chronopoulos; P Hyde; S Thurber; A Gatt; Z Liu; S Werner; C E Stafstrom
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

9.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Lancet Neurol       Date:  2013-01-23       Impact factor: 44.182

10.  Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy.

Authors:  Jinsook Kim; Alexei Kondratyev; Karen Gale
Journal:  J Pharmacol Exp Ther       Date:  2007-07-16       Impact factor: 4.030

View more
  27 in total

Review 1.  Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.

Authors:  Elissa Yozawitz; Arthur Stacey; Ronit M Pressler
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

2.  Thalamocortical Connections and Executive Function in Pediatric Temporal and Frontal Lobe Epilepsy.

Authors:  N Law; M L Smith; E Widjaja
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-07       Impact factor: 3.825

3.  Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus.

Authors:  Renée A Shellhaas; Anne T Berg; Zachary M Grinspan; Courtney J Wusthoff; John J Millichap; Tobias Loddenkemper; Jason Coryell; Russell P Saneto; Catherine J Chu; Sucheta M Joshi; Joseph E Sullivan; Kelly G Knupp; Eric H Kossoff; Cynthia Keator; Elaine C Wirrell; John R Mytinger; Ignacio Valencia; Shavonne Massey; William D Gaillard
Journal:  Pediatr Neurol       Date:  2017-06-27       Impact factor: 3.372

4.  Treatment Duration After Acute Symptomatic Seizures in Neonates: A Multicenter Cohort Study.

Authors:  Renée A Shellhaas; Taeun Chang; Courtney J Wusthoff; Janet S Soul; Shavonne L Massey; Catherine J Chu; M Roberta Cilio; Sonia L Bonifacio; Nicholas S Abend; Tammy N Tsuchida; Hannah C Glass
Journal:  J Pediatr       Date:  2016-11-07       Impact factor: 4.406

5.  "Endovascular embolic hemispherectomy": a strategy for the initial management of catastrophic holohemispheric epilepsy in the neonate.

Authors:  Chima Oluigbo; Monica S Pearl; Tammy N Tsuchida; Taeun Chang; Cheng-Ying Ho; William D Gaillard
Journal:  Childs Nerv Syst       Date:  2016-10-29       Impact factor: 1.475

6.  Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial.

Authors:  Cynthia Sharpe; Gail E Reiner; Suzanne L Davis; Mark Nespeca; Jeffrey J Gold; Maynard Rasmussen; Rachel Kuperman; Mary Jo Harbert; David Michelson; Priscilla Joe; Sonya Wang; Neggy Rismanchi; Ngoc Minh Le; Andrew Mower; Jae Kim; Malcolm R Battin; Brian Lane; Jose Honold; Ellen Knodel; Kathy Arnell; Renee Bridge; Lilly Lee; Karin Ernstrom; Rema Raman; Richard H Haas
Journal:  Pediatrics       Date:  2020-05-08       Impact factor: 7.124

7.  Children with epilepsy demonstrate macro- and microstructural changes in the thalamus, putamen, and amygdala.

Authors:  Sarah J MacEachern; Jonathan D Santoro; Kara J Hahn; Zachary A Medress; Ximena Stecher; Matthew D Li; Jin S Hahn; Kristen W Yeom; Nils D Forkert
Journal:  Neuroradiology       Date:  2019-12-18       Impact factor: 2.804

8.  Preclinical safety and efficacy of cannabidivarin for early life seizures.

Authors:  Megan N Huizenga; Alberto Sepulveda-Rodriguez; Patrick A Forcelli
Journal:  Neuropharmacology       Date:  2019-01-10       Impact factor: 5.250

9.  Anticonvulsant effect of flupirtine in an animal model of neonatal hypoxic-ischemic encephalopathy.

Authors:  Dayalan Sampath; Robert Valdez; Andrew M White; Yogendra H Raol
Journal:  Neuropharmacology       Date:  2017-06-03       Impact factor: 5.250

10.  Neuroprotective Action of the CB1/2 Receptor Agonist, WIN 55,212-2, against DMSO but Not Phenobarbital-Induced Neurotoxicity in Immature Rats.

Authors:  Megan N Huizenga; Patrick A Forcelli
Journal:  Neurotox Res       Date:  2018-08-24       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.